The estimated Net Worth of Casper Breum is at least $1.46 millió dollars as of 6 November 2017. Casper Breum owns over 214,285 units of Spero Therapeutics Inc stock worth over $1,462,977 and over the last 7 years Casper sold SPRO stock worth over $0.
Casper has made over 1 trades of the Spero Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Casper bought 214,285 units of SPRO stock worth $2,999,990 on 6 November 2017.
The largest trade Casper's ever made was buying 214,285 units of Spero Therapeutics Inc stock on 6 November 2017 worth over $2,999,990. On average, Casper trades about 107,143 units every 0 days since 2017. As of 6 November 2017 Casper still owns at least 1,091,774 units of Spero Therapeutics Inc stock.
You can see the complete history of Casper Breum stock trades at the bottom of the page.
Casper's mailing address filed with the SEC is C/O LUNDBECKFOND INVEST A/S, SCHERFIGSVEJ 7, COPENHAGEN, G7, DK-2100.
Over the last 15 years, insiders at Spero Therapeutics Inc have traded over $15,920,732 worth of Spero Therapeutics Inc stock and bought 3,223,281 units worth $44,767,755 . The most active insiders traders include Plc Gsk, Jean Francois Formela és Capital Management, Llc Aqu.... On average, Spero Therapeutics Inc executives and independent directors trade stock every 71 days with the average trade being worth of $122,858. The most recent stock trade was executed by Ankit Mahadevia on 27 August 2024, trading 5,912 units of SPRO stock currently worth $7,981.
spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.
Spero Therapeutics Inc executives and other stock owners filed with the SEC include: